Biotech
Gameto
Gameto raises $44M Series C at $250M valuation
Austin, TXSeptember 27, 20251 min read
Total Raised
$44M
Valuation
$250M
Latest Round
Series C
Employees
60+
Gameto: Series C Funding Round
Gameto has successfully raised $44M in Series C funding, reaching a valuation of $250M.
Company Overview
Stem cell-derived therapies for reproductive health
Funding Details
The Series C round was led by Future Ventures, with participation from Khosla Ventures.
Company Information
- Headquarters: Austin, TX
- Founded: 2020
- Employees: 60+
- Category: Biotech
Investment
Gameto plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Future Ventures: Verified investor in Series C
- Khosla Ventures: Verified investor in Series C
Company Info
Headquarters
Austin, TX
Founded
2020
Team Size
60+
Last Round
$44M(Sep 2025)
Investors (2)
F
Future VenturesLeadLead Investor
Verified investor in Series C
K
Khosla VenturesInvestor
Verified investor in Series C
Share
Related Reports
Biotech
AusperBio
AusperBio Raises $73M Series B
Biotech company developing AHB-137, an antisense oligonucleotide for chronic hepatitis B treatment entering phase 2 trials
David Chen
Dec 30, 2025
0 min read•$73M Series B
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free